|Age:||1 years or older|
|Keywords:||Renal Cell Carcinoma, kidney cancer, TFE/Translocation Renal Cell Carcinoma, tRCC|
|Type:||Drug study, Phase 2|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.
= 16 years - 1.7 mg/dL (male), 1.4 mg/dL (female)
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.